Examining Men’s Status Shield and Status Bonus: How Gender Frames the Emotional Labor and Job Satisfaction of Nurses
Abstract (Hochschild 1983) coined the term status shield to theorize men’s status-based protection from the emotional abuses of working in a service job and hence their diminished need to manage emotions as compared to women. Extending this concept, the current study examines how gender operates not merely to shield men from emotional labor on the job but to also shape the relationship between emotional labor and job satisfaction. Using survey data collected from 730 registered nurses (667 women and 63 men) at a large Midwestern hospital system in the U.S., we show that in addition to engaging in less emotional labor than women, men benefit from their emotion management in ways that women do not. Gender moderates the relationship between two dimensions of emotional labor (i.e., surface acting – covering emotion and deep acting) and two outcome measures (i.e., job satisfaction and turnover intention). Results support theoretical claims that men’s privileged status shields them from having to perform emotional labor as frequently as women. Further, when male nurses do perform higher levels of emotional labor, they are shielded from the negative effects of covering emotion and their deep acting correlates with higher job satisfaction—a status bonus—compared to that of their female colleagues. Implications for gender theory, emotional labor, and nursing policy and practice are discussed.
CONCLUSIONS: The concept of soldier-centered care often emerges in discussions about optimal physical performance and medical readiness for soldiers. Although soldier-centered care and patient-centered care have similar conceptual underpinning, it is important to clarify the unique physical and medical requirements for soldiers that differentiate soldier-centered care from patient-centered care. Implementing the defining attributes of soldier-centered care in the U.S. Army primary care setting may improve the quality of care and health outcomes for soldiers. When defining performance metrics for primary care models of care...
Authors: Waller SG Abstract Three important but neglected principles of evaluation of global health engagement missions are stakeholder engagement, impact, and relative value. Implementing better M&E programs could be carried out in this fiscal year, without new appropriations or manpower. The result would be cost savings and improved security cooperation. PMID: 31942621 [PubMed - as supplied by publisher]
Publication date: Available online 18 January 2020Source: Clinica Chimica ActaAuthor(s): Guodong Zhao, Yong Ma, Hui Li, Shiming Li, Yun Zhu, Xiaoyu Liu, Shangmin Xiong, Yi Liu, Jin Miao, Sujuan Fei, Minxue Zheng, Xiangwei ZhaoAbstractBackgroundMethylated SFRP2 was previously reported as a non-invasive biomarker for colorectal cancer (CRC) detection with a relatively low sensitivity for early stage CRC. The purpose of this study was to evaluate the performance of a new plasma based CRC screening assay, SpecColon test, which tested methylated SFRP2 and SDC2 simultaneously in a single qPCR reaction, in detecting CRC and advan...
CONCLUSIONS: MHR may be a significant and independent predictor of poor functional outcome in patients with AIS. PMID: 31941849 [PubMed - as supplied by publisher]
Authors: Ieda N, Assadullah, Minabe S, Ikegami K, Watanabe Y, Sugimoto Y, Sugimoto A, Kawai N, Ishii H, Inoue N, Uenoyama Y, Tsukamura H Abstract Accumulating evidence suggests that kisspeptin neurons in the arcuate nucleus (ARC), which coexpress neurokinin B and dynorphin, are involved in gonadotropin-releasing hormone (GnRH)/luteinizing hormone (LH) pulse generation, while the anteroventral periventricular nucleus (AVPV) kisspeptin neurons are responsible for GnRH/LH surge generation. The present study aims to examine whether GnRH(1-5), a GnRH metabolite, regulates LH release via kisspeptin neurons. GnRH(1-5) was...
In conclusion, caffeine decreased oxidative stress and adipogenesis in GO orbital fibroblasts in vitro. These findings may contribute to the development of new types of caffeine-containing pharmacological agents for use in the management of GO. PMID: 31941844 [PubMed - as supplied by publisher]